INDEPENDENT, SCALABLE AND SPECIALIZED

Real-World Data for Rapid Insights

ConcertAI’s rich suite of independent real-world data products are fit-for-purpose to meet a variety of research needs and use cases across the enterprise

Contact Us
 
10+

EMR Systems

90%

Clinical EMR-Open Claims Overlap

200+

Structured Variables

100+

Abstracted Variables

4.5Y

Average Longitudinal Follow-up Time

600+

Biomarkers

10+

AI Models

What Data Trained Your AI?

LEADING INNOVATORS

On-Demand Data for
Accelerated Research

  • Post-Approval
  • Clinical Development
  • Comparative effectiveness in real-world populations compared to clinical trials
  • Study feasibility analyses
  • Patient population comparisons and analytics
  • Characteristics of patient journey and treatment sequencing over time
  • Adverse event detection and evaluation
  • Treatment patterns and analysis
  • Biomarker data impact on treatment selection and outcomes
  • External control arms
  • Clinical trial protocol development and optimization
  • Identification of undiagnosed and under-treated patient groups
  • Study feasibility analyses
  • Patient population comparisons and analytics
  • Characteristics of patient journey and treatment sequencing over time
  • Adverse event detection and evaluation
  • Treatment patterns and analysis
  • Biomarker data impact on treatment selection and outcomes
Data Products

AI-Enriched Real-World Data Products

AI-Enriched Real-World Data Products
Structured EMR Insights for Large-Scale Analyses

RWD360™

RWD360®

RWD360® is a vast repository of pan tumor clinical data for broad analyses and hypothesis generation. Validated AI models enrich data for scale; claims linkage provides more complete insights into patient journeys.

Request a Demo

All Solid Tumors and Hematologic Malignancies
All Solid Tumors and
Hematologic Malignancies
Broad Geographic
Broad Geographic
Coverage
AI-Enriched and Sophisticated Models
AI-Enriched and
Sophisticated Models

Reasons for RWD360®

Request Information
Compare Characteristics

Compare demographic characteristics based on different treatments.

See Treatment Sequencing

See how treatments and drug class exposures being sequenced in a cohort.

Combine Clinical Criteria

Sub-cohort insights with a combination of clinical criteria like ECOG, early-stage disease, histology, blood-test results, BMI, etc.

Customer Value for RWD360®

Clinical Development Teams

Rapidly generate insights into standard of care with on-demand access to thousands of data elements and accelerate innovation and drug discovery timelines.

Predictive AI and Data Scientists

Explore AI-driven models from predicting outcomes to classifying critical patient sub-cohorts, ConcertAI is at the forefront of innovation demonstrated by our wide range of papers in this rapidly evolving area.

Business Development Leaders

Centralize enterprise data needs with the ability to easily combine disparate datasets and shorten forecasting workflows with richer clinical data at the population level.

EXPERTLY ABSTRACTED DATA FOR RESEARCH PURPOSES AND PUBLICATION

Patient360

Patient360™

Patient360™ is an off-the-shelf, deeply abstracted data product that removes the need for bespoke curation and allows direct insights into current standard of care on emerging disease and treatment dynamics.

Request a Demo

Deepest Industry Abstraction
Deepest Industry Abstraction
On-Demand Datasets
On-Demand Datasets

Reasons for Patient360™

Request Information
Identify Study Feasibility

Identify base rates of clinical characteristics, disease severity measures and treatment outcomes in real world treatment to inform the feasibility of using RWD as a comparator arm.

Post-Approval RWD

Conduct effectiveness outcomes studies in specific populations of interest and compare to clinical trials.

Track Safety

See adverse events experienced by real-world populations and compare to clinical trials.

Customer Value for Patient360™

Clinical Development Leaders

Rapidly generate relevant insights into standard of care, develop novel research studies, and shorten drug development timelines.

Post-Approval/Epi-Safety Executives

Bring automation and data science to post-marketing analytics, comparative effectiveness studies, and risk surveillance.

Brand Managers

Assess and monitor treatment journeys and adherence patterns for strategic development and post-launch planning

Which Cancers Can I Research?

MM

MM

Bladder

Bladder

Breast

Breast

Gastric-Esophageal

Gastric-Esophageal

Liver

Liver

Lung

Lung

Melanoma

Melanoma

Pancreatic

Pancreatic

Prostate

Prostate

Renal

Renal
All Other Cancers
Research Study

Performance of Proxy Measures Compared with Direct Observation of Progression-Free Survival

See results from findings presented at ISPOR 2020 and ASCO 2020 on the performance of proxy measures against directly-observed measures of PFS by using structured and unstructured information from ConcertAI’s Oncology Real-World Database.

See Research Study
Performance of Proxy Measures Compared with Direct Observation of Progression-Free Survival
DEEP CLINICO-GENOMICS DATA

Genome360

Genome360™

Genome360™ provides in-depth understanding of treatment profiles with data from NGS panels and structured and unstructured fields.

Request a Demo

Full NGS Panel
Full NGS Panel
Linked Clinical-Genomic
Linked Clinical-Genomic
Deepest Industry Abstraction
Deepest Industry Abstraction

Reasons for Genome360™

Request Information
Biomarker Testing Results

See biomarker testing, results, and timing and understand trends and how they change over time.

Identify Patients by Gene Variants

Identify patients by any type of variant in a given gene, e.g. mutation, amplification, rearrangement, etc.

Assess Treatments and Outcomes

Assess how testing (and additionally, positivity) affects treatment selection and outcomes.

Customer Value for Genome360™

Clinical Development Leaders

Rapidly generate relevant insights into standard of care, develop novel research studies, and shorten drug development timelines.

Post-Approval/Epi-Safety Executives

Bring automation and data science to post-marketing analytics, comparative effectiveness studies, and risk surveillance.

Brand Managers

Assess and monitor treatment journeys and adherence patterns for strategic development and post-launch planning.

Tailored Abstraction & Analytics

Custom Data Services for Specific Research Needs

Our team of HEOR and clinical oncology experts build unique data assets to support research questions that demand deeper insights.

Custom Data Services for Specific Research Needs

Request a Demo

Oncology and HEOR Expertise
Oncology and HEOR Expertise
Extensive Knowledge of RWD
Extensive Knowledge of RWD
Biostatistical Design and Execution
Biostatistical Design and Execution
Regulatory Support and Publications
Regulatory Support and Publications

See Publications

Our scientific team regularly publishes with our clients based on research using custom data across a variety of therapeutic areas.

See the Research

Reasons for ConcertAI Custom Data

Request Information
Precise Patient Journeys

Create bespoke datasets to explore the real-world treatment landscape

Depth of Information

Customize datasets for granular insights into specific outcomes and endpoints

Longitudinal Datasets

Commission datasets to function as EMR registries